Penserra Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Buy
13,431
+6,626
+97% +$314K 0.01% 561
2025
Q4
$346K Sell
6,805
-87
-1% -$4.45K ﹤0.01% 588
2025
Q3
$382K Buy
6,892
+2,144
+45% +$125K ﹤0.01% 618
2025
Q2
$327K Sell
4,748
-3,083
-39% -$210K ﹤0.01% 560
2025
Q1
$543K Buy
7,831
+1,794
+30% +$148K 0.01% 580
2024
Q4
$519K Buy
6,037
+618
+11% +$66.8K 0.01% 559
2024
Q3
$645K Sell
5,419
-40,913
-88% -$5.46M 0.01% 497
2024
Q2
$6.61M Buy
46,332
+15,762
+52% +$2.09M 0.08% 196
2024
Q1
$3.92M Buy
30,570
+23,006
+304% +$2.74M 0.05% 259
2023
Q4
$782K Sell
7,564
-20,769
-73% -$2.05M 0.01% 422
2023
Q3
$2.58M Buy
+28,333
New +$2.5M 0.05% 231
2023
Q2
Sell
-8,052
Closed -$640K 1303
2023
Q1
$640K Buy
8,052
+5,856
+267% +$415K 0.01% 446
2022
Q4
$148K Buy
2,196
+1,464
+200% +$85.8K ﹤0.01% 745
2022
Q3
$36K Buy
+732
New +$39.2K ﹤0.01% 841

Other funds holding NVO